Evidence map›Paper›PMID 31557915›Full record

ArticlePathogens (Basel, Switzerland)2019

First Detection of Carbapenem-Resistant

Tomilola Adesina, Obinna Nwinyi, Nandita De, Olayemi Akinnola, Emmanuel Omonigbehin

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Potentially Virulent Multi-Drug ResistantDiagnostics (Basel, Switzerland) · 2023
    Article
  9. Case report: Fatal neonatal sepsis associated withFrontiers in veterinary science · 2023
    Article
  10. Article
  11. Avian strains of emerging pathogenFrontiers in microbiology · 2022
    Article
  12. Beta-lactamase resistance genes inAfrican journal of laboratory medicine · 2022
    Review
  13. Genomic Characterization of TwoFrontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Preponderance ofFrontiers in microbiology · 2021
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tomilola AdesinaDepartment of Microbiology, College of Science and Technology, Covenant University, 112103 Ota, Nigeria. tomilola.adesina@stu.cu.edu.ng.ORCID 0000-0001-6679-5377
Obinna NwinyiDepartment of Microbiology, College of Science and Technology, Covenant University, 112103 Ota, Nigeria. obinna.nwinyi@covenantuniversity.edu.ng.ORCID 0000-0001-9314-6460
Nandita DeDepartment of Microbiology, College of Science and Technology, Covenant University, 112103 Ota, Nigeria. manadina93@gmail.com.
Olayemi AkinnolaDepartment of Microbiology, College of Science and Technology, Covenant University, 112103 Ota, Nigeria. ola.ayepola@covenantuniversity.edu.ng.
Emmanuel OmonigbehinDepartment of Microbiology, College of Science and Technology, Covenant University, 112103 Ota, Nigeria. adedayo.omonigbehin@covenantuniversity.edu.ng.
Covenant University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently discovered extraintestinal

Indexed as

antibiotics resistancebeta-lactamase genecarbapenem resistanceEscherichia coliEscherichia fergusoniiExtended-spectrum beta-lactamase (ESBL)extraintestinal pathogenmultidrug resistanceWound infections

Identifiers

PMID31557915
PMCPMC6963453
OpenAlexW2975859519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.